Tenet Healthcare Co. (NYSE:THC) Insider R. Scott Ramsey Sells 11,599 Shares

Tenet Healthcare Co. (NYSE:THCGet Free Report) insider R. Scott Ramsey sold 11,599 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $162.06, for a total transaction of $1,879,733.94. Following the completion of the transaction, the insider now directly owns 6,324 shares in the company, valued at $1,024,867.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Tenet Healthcare Trading Down 5.3 %

NYSE:THC opened at $153.41 on Friday. Tenet Healthcare Co. has a 52 week low of $51.04 and a 52 week high of $166.89. The firm’s fifty day moving average is $147.68 and its 200-day moving average is $125.51. The firm has a market cap of $14.99 billion, a P/E ratio of 5.95, a P/E/G ratio of 0.85 and a beta of 2.14. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.38 and a current ratio of 1.45.

Tenet Healthcare (NYSE:THCGet Free Report) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $2.31 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.42. Tenet Healthcare had a return on equity of 24.66% and a net margin of 13.17%. The firm had revenue of $5.10 billion during the quarter, compared to analyst estimates of $4.98 billion. Equities analysts expect that Tenet Healthcare Co. will post 10.7 earnings per share for the current year.

Tenet Healthcare declared that its board has initiated a share repurchase program on Wednesday, July 24th that allows the company to buyback $1.50 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 10.3% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently modified their holdings of the stock. Innealta Capital LLC bought a new stake in Tenet Healthcare in the second quarter valued at $28,000. ORG Partners LLC bought a new stake in Tenet Healthcare in the 2nd quarter valued at about $31,000. Blue Trust Inc. boosted its holdings in Tenet Healthcare by 93.0% in the second quarter. Blue Trust Inc. now owns 249 shares of the company’s stock worth $33,000 after acquiring an additional 120 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in Tenet Healthcare in the second quarter valued at approximately $34,000. Finally, Rise Advisors LLC acquired a new position in shares of Tenet Healthcare during the first quarter worth approximately $29,000. Institutional investors own 95.44% of the company’s stock.

Analysts Set New Price Targets

THC has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on Tenet Healthcare from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Truist Financial restated a “buy” rating and issued a $170.00 target price (up previously from $155.00) on shares of Tenet Healthcare in a research report on Thursday, July 25th. Citigroup increased their price target on Tenet Healthcare from $139.00 to $171.00 and gave the company a “buy” rating in a research note on Thursday, July 25th. The Goldman Sachs Group boosted their price objective on Tenet Healthcare from $156.00 to $173.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Finally, Robert W. Baird began coverage on Tenet Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $153.00 price target on the stock. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Buy” and a consensus price target of $152.69.

View Our Latest Stock Report on THC

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.